32 related articles for article (PubMed ID: 8760583)
1. Differential p16 expression levels in the liver, hepatocytes and hepatocellular cell lines.
Kramar B; Šuput D; Milisav I
PeerJ; 2021; 9():e12358. PubMed ID: 34760375
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma.
Tang J; Xie Y; Xu X; Yin Y; Jiang R; Deng L; Tan Z; Gangarapu V; Tang J; Sun B
Cell Death Dis; 2017 Mar; 8(3):e2675. PubMed ID: 28300839
[TBL] [Abstract][Full Text] [Related]
3. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.
Zhao H; Zhang Y; Sun J; Zhan C; Zhao L
Oncol Res; 2016; 23(5):237-48. PubMed ID: 27098147
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.
Nishida N; Goel A
Curr Genomics; 2011 Apr; 12(2):130-7. PubMed ID: 21966251
[TBL] [Abstract][Full Text] [Related]
5. H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells.
Yao JY; Zhang L; Zhang X; He ZY; Ma Y; Hui LJ; Wang X; Hu YP
J Biol Chem; 2010 Jun; 285(24):18828-37. PubMed ID: 20382980
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
Matsuda Y
World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
[TBL] [Abstract][Full Text] [Related]
7. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis.
Matsuda Y; Ichida T
Med Mol Morphol; 2006 Dec; 39(4):169-75. PubMed ID: 17187177
[TBL] [Abstract][Full Text] [Related]
8. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma.
Chu HJ; Heo J; Seo SB; Kim GH; Kang DH; Song GA; Cho M; Yang US
J Korean Med Sci; 2004 Feb; 19(1):83-6. PubMed ID: 14966347
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma.
Qin Y; Li B; Tan YS; Sun ZL; Zuo FQ; Sun ZF
World J Gastroenterol; 2000 Jun; 6(3):411-414. PubMed ID: 11819612
[No Abstract] [Full Text] [Related]
11. Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus.
Kaneto H; Sasaki S; Yamamoto H; Itoh F; Toyota M; Suzuki H; Ozeki I; Iwata N; Ohmura T; Satoh T; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Omata M; Imai K
Gut; 2001 Mar; 48(3):372-7. PubMed ID: 11171828
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
14. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A (p16INK4A) somatic and germline mutations.
Smith-Sørensen B; Hovig E
Hum Mutat; 1996; 7(4):294-303. PubMed ID: 8723678
[TBL] [Abstract][Full Text] [Related]
18. Infrequent alterations of the p16INK4A gene in liver cancer.
Kita R; Nishida N; Fukuda Y; Azechi H; Matsuoka Y; Komeda T; Sando T; Nakao K; Ishizaki K
Int J Cancer; 1996 Jul; 67(2):176-80. PubMed ID: 8760583
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
